31 submissions from 29 organizations told the European Commission what they think about this file. Here is what each of them said, in their own words.
The Commission lists 38 submissions on this file. Shown here: the 31 from organizations. Not shown, by design: submissions from private individuals, which we never publish, and anything filed since our last weekly refresh.
Who showed up
2 submissions from industry — companies and their trade associations — against 22 from civil society: NGOs, consumer organizations, environmental groups and trade unions.
Industry 2Civil society 22Public authorities, academia, other 7
Groupings use the respondent type each organization selected when filing. Counting submissions, not organizations — a body that filed twice is counted twice.
What the room declares
10 of 29
in the EU Register
16
full-time lobbying staff
€500K+
declared costs a year
0
EP accreditations declared
Self-declared to the EU Transparency Register (snapshot 2 Sept 2026). The cost figure sums band floors, so the true total is higher.
The file, right now
The consultation closed on 21 Apr 2022 — it ran from 14 Jan 2022.
Metzineres is a non-profit cooperative, based in Barcelona (Spain), aimed at deploying shelter environments for women and non-binary people using drugs and surviving violence and integrating the full spectrum of harm reduction.
Filed in Spanish · English published by the European Commission
As a member of the CSFD, Fedito Bxl, the federation of the drugs and addictions sector in the Brussels region, welcomes the renewed and upscaled mandate for the EMCDDA. Its role in providing solid scientific data on drug-related matters cannot be overstated, and as such the EMCDDA is a critical actor in the development of evidence-based policies and interventions in the field of drugs and addictions.
Metrc appreciates the opportunity to provide comments on the proposal for a regulation on the EU drugs agency. Metrc is a U.S.-based company offering the leading solution for cannabis governance through track-and-trace technology, which centrally records inventory, test results, and movement of cannabis plants and products.
As the Droghe Forum Association, we think that the EMCDDA has always been an important, scientifically valid source aimed at improving Europe’s and the Member States’ ability to take effective and appropriate action on the phenomena of substance consumption in the light of changing scenarios and consumption styles.
Filed in Italian · English published by the European Commission
UNAD, founded in 1985, is an umbrella organization integrated by 207 ngos from Spain that work in the field of drug demand reduction, Including prevention, early detection and, intervention, risk and harm reduction, treatment, social reintegration and recovery of drug users and its families.
The EMCDDA has a 30y history by now and in many ways the EMCDDA was very helpful for many European decisions, development of action and strategy plans. The focus always lied on demand and harm reduction. In this context we cooperated in particular on demand and harm reduction strategies in general and in particular in prison settings.
Correlation-European Harm Reduction Network (C-EHRN) welcomes a renewed mandate for the EMCDDA. The EMCDDA plays a crucial role in collecting and analysing reliable data and in building and promoting evidence-based interventions in the field of drug demand reduction.
The International Drug Policy Consortium (IDPC) is a network of +190 NGOs – including dozens of European NGOs – that seek to reform drug policies in order to advance social justice and human rights. IDPC welcomes a renewed mandate for the EMCDDA, as it plays a critical role in supporting evidence-based drug policies across the EU, and more broadly globally.
As a member of the CSFD, Fundación Fad Juventud welcomes a renewed mandate for the EMCDDA, as it plays a critical role in collecting and analysing reliable data and in facilitating the development and implementation of evidence-based drug policies across the EU. A stronger, well-funded agency is therefore to be applauded.
On behalf of World Federation Against Drugs (WFAD) we would like to state our support of the comments made by EURAD and San Patrignano in regard to the new EMCDDA mandate. In addition, WFAD wishes to encourage the EUDA to help develop evidence-based, gender-transformative and trauma-informed strategies in treatment and recovery services – to better support the needs of all genders and reduce barriers faced by women…
EURAD is a European non-profit drug policy network that advocates for prevention, treatment and recovery oriented drug policies at the national and international level. Our mission is to to reduce the burden of harm caused by non-medical drug use to individuals, families and communities through public health oriented policies that seek to prevent drug use, offer early intervention, provide access to health…
San Patrignano is an NGO in consultaitve status witth ECOSOC and member of the Civil Society Forum on Drugs.Since 1978 we have been working in the area of prevention, recovery and social reintegration of people with substance use disorder and advocating for prevention and recovery oriented drug policies at the national and international level.
Correlation-European Harm Reduction Network (C-EHRN) welcomes a renewed mandate for the EMCDDA. The EMCDDA plays a crucial role in collecting and analysing reliable data and in building and promoting evidence-based interventions in the field of drug demand reduction.
As an organization working in drug policy in Poland and as drug policy professionals we happily give feedback on the work and mandate of the European monitoring centre. The EMCDDA's produced content and its expertise and help has been of the highest quality and usefulness to our work.
The Global Drug Policy Program (GDPP) of the Open Society Foundations (OSF) has existed since 2008 and promotes drug policies rooted in human rights, sustainable development, social and racial justice, and public health. We work with policymakers, academics, and grassroots groups all over the world, including in Europe.
During my long professional career I had opportunity to collaborate with EMCDDA and to observe its impressing development. In the beginning of century I was first head of EMCDDA Polish focal point and than I collaboreted and still collaborate as a expert.
Instituto RIA is a Mexican-based organization that undertakes high quality research, highlighting and proposing innovations in order to advocate for public policies within a social justice and peace building framework.
EURAD is a European non profit drug policy Foundation that advocates for prevention and recovery oriented drug policies at national and international level. We would like to thank DG Home for the opportunity to provide feedback on the revision of the mandate of the EMCDDA. In our work we regularly rely on data and analyses from EMCDDA.
DEAR members of Unit D5 — Organised Crime and Drugs Policy, within the Directorate General Migration and Home Affairs, On behalf of the National Anti-drug Agency in Romania, I would like to provide a feedback on the reception impact assessment (IIA), regarding the EMCDDA’s term revision.
Filed in Romanian · English published by the European Commission
I am writing on behalf of the Technical Secretary for Drug Dependencies of the Extremadura Health Service, Second Vice-Presidency and Ministry of Health and Social Services of the Extremadura Regional Government.
The International Drug Policy Consortium (IDPC), a network of over 195 NGOs promoting drug policy reform on the basis of public health, human rights, and social justice, welcomes the opportunity to provide feedback to the Inception Impact Assessment concerning the revision of the mandate of the European Monitoring Centre for Drugs and Drug Addiction Agency (EMCDDA or the Agency). 1.
The European AIDS Treatment Group (EATG) is a patient-led advocacy NGO that defends the treatment-related interests of people living with or affected by HIV/ AIDS and related co-infections within Europe. Founded in 1992, the EATG is a network of more than 180 nationally-based members from 47 countries in Europe.
EMCDDA’s work and publications are highly needed and useful at a national level to promote evidence based knowledge, best practices and strategies to implement efficient actions and to improve the way all communities can cope with all types of drug issues. A public health focus shall be at the centre of all the other possible focus.
Finding: According to the WHO, alcohol is responsible for one million deaths per year in Europe (WHO region — 53 countries), caused by cardiovascular disease, violence and suicide, involuntary deaths (falling, drowning, road accidents), diseases (cancer, cirrhosis), etc. At EU level, very few data are available on harmful alcohol consumption and their effects.
Filed in French · English published by the European Commission
Having no formal but frequent contacts with the EMCDDA since its inception I can confirm that it has achieved a position of a hub of excellence in Europe and offers the information which is factual, objective, reliable and robust. The information gives a comparative perspective which is very useful for scientific and policy purposes at the European and national levels.
Pompidou Group Secretariat Feedback on the revision of the mandate of the EMCDDA The Pompidou Group Secretariat highly values the cooperation with the EMCDDA, on the basis of the 2009 MoU signed between the two institutions, whose appendix has been updated in February 2020. It therefore supports options which would strengthen the EMCDDA's role and relevance, and open new prospects for synergies.
We expect that the findings of the EMCDDA evaluation will be taken into account when reviewing the EMCDDA responsibilities. Also, we really hope that, even if new responsibilities are added, the current work done by EMCDDA remains funded, at least at the current level..
During the last two decades the Centre for Interdisciplinary Addiction Research of the University of Hamburg (ZIS) has been involved as a scientific coordinator or cooperating partner in various EU projects on illicit drug use.
I am writing on behalf of Dianova International, an international NGO based in 19 countries in 4 continents. We work in the fields of health and social care. In the field of drugs we have been providing treatment and prevention service for almost four decades. We work at the grassroots and advocacy level. Dianova heavily relies on the EMCDDA’s work.
On the revision of the mandate of the European Monitoring Centre for Drugs and Drug Addiction At the Spanish Society of Public Health and Health Administration (SSPAS), the leading professional and scientific organisation in the field in Spain pools process.
Filed in Spanish · English published by the European Commission
The European Monitoring Centre on Drug Addiction should be responsible for ensuring good practice at the level of research, prevention and care of drug addiction, moving away from strict monitoring of drug trafficking, as this task should be left to the hands of the police structures of each country and of the inter-pol.
Filed in Spanish · English published by the European Commission
Method. Every quote is verbatim from the organization’s own submission to the European Commission, trimmed to its opening passage and never summarized by a model. Where a submission was filed in another EU language we show the English text the European Commission publishes alongside it, labeled on the quote; the original is one click away at the source. Groupings use the respondent type the organization itself selected when filing. We deliberately do not label anyone “supportive” or “opposed” — you read what they wrote and draw your own conclusion. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.